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Abstract   The Chilean salmon farming industry is currently facing unprecedented 
economic losses related to the infectious salmon anemia (ISA) disease. Production of 
Atlantic salmon is being reduced from almost 400,000 tonnes in 2005 to an estimated 
100,000 tonnes in 2010. The spread of and response to the disease raises a number 
of important issues with respect to the actions of the companies involved as well as 
the regulatory body. It is particularly interesting that adequate measures have not 
been implemented in Chile, as the species is farmed in relatively few countries and, 
as such, is fairly transparent. Moreover, all other major salmon- producing countries 
have experienced the disease, and several of the largest companies in Chile are multi-
nationals with first-hand experience with ISA from other countries.
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Introduction
Currently, the Chilean salmon aquaculture industry is experiencing the worst disease out-
break ever observed in salmon aquaculture and, in terms of revenue losses, possibly in all 
aquaculture so far. In 2007, the world’s largest salmon-producing company, Marine Har-
vest, reported that they had discovered infectious salmon anemia (ISA) at a farm producing 
Atlantic salmon in Chile. This was the first report of the disease in Chile. however, reports 
of new outbreaks have increased rapidly since then, and industry sources are now indicating 
that in 2009 the smolt release will be less than 10% of what it was in 2007 (Carvajal 2009).
 because the production cycle for salmon lasts between 1.5 and 2.5 years, the full im-
pact of this disease on production started to appear in 2009 and will not fully be realized 
in the production figures before 2010. The numbers that are being reported are dramatic, 
as production of Atlantic salmon in Chile is expected to decrease from 211,000 tonnes in 
2009 to a little more than 98,000 tonnes in 2010, down from 379,000 tonnes in 2007 and 
386,000 tonnes in 2006 (kontali 2009; FAO 2009).
 While salmon disease itself is not new, the magnitude of the outbreak in Chile is 
staggering. Moreover, it raises a number of questions regarding disease management in 
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salmon aquaculture and should provide lessons not only for salmon producers but for 
producers of other aquaculture species as well. As salmon is produced in relatively few 
countries, it is easier to obtain information about the spread of diseases and their treat-
ment than for other species that are produced in a larger number of countries. 
 In this article we will provide a preliminary discussion of the disease outbreak in 
Chile. We expect that a number of analyses will be carried out in the future as the out-
break plays out and more information is provided.
Diseases in Salmon Aquaculture
Disease is present in all animal production, including aquaculture, and as a result disease man-
agement is an intrinsic part of animal production (bicknell, Wilen, and howitt 1999). There 
have been large outbreaks for all major aquaculture species, and with shrimp and salmon as the 
most valuable species, the value of the production loss has been largest for them.
 There are a number of known diseases for salmon, including: vibrosis, furunculosis, 
Pancreas disease (PD), infectious hematopoietic necrosis (ihn), and infectious salmon 
anemia (iSA). Disease started to be detected in the early 1980s, and as such, has followed 
the industry through its development. At times, disease has threatened the industry’s 
existence because of the economic losses following a period of significant reductions in 
production and destruction of infected fish. Among the most significant outbreaks are vi-
brosis in norway in 1986, furunculosis in norway in the early 1990s, and iSA in the bay 
of Fundy in Canada just after the turn of the century, and the Faroe Island in 2003. So far, 
the ISA outbreak in the Faroe Islands is certainly the most serious in relative terms, and it 
is most likely also the most serious when it comes to production loss, as production was 
reduced from 47,000 tonnes in 2004 to 12,000 tonnes in 2006 before it started to rebound.
 It is also worthwhile to note that there are no recorded major disease outbreaks of 
any kind in Scotland and no major outbreaks of ISA in Norway. This is the case despite 
several isolated ISA outbreaks in both countries.1 However, while these outbreaks have 
been serious for single companies, and also regions at times, the spread of the disease 
has been limited. There are several ways to contain a disease. Some diseases, such as vi-
brosis and furunculosis are not really a threat anymore because of effective vaccines. For 
others, lack of or less effective vaccines make other measures, such as zoning of farms, 
regulations of distances between farms, and destruction of fish when a disease is detected, 
important tools in disease management. Regulatory tools are necessary to implement such 
measures, and experiences of the regulatory bodies and individual firms in combating dis-
ease lead to more efficient disease management schemes.
 It is hard to obtain good data on most issues related to disease. However, antibi-
otic use in Norway presents an interesting illustration of changes in the measures used 
for combating disease. Figure 1 shows total Norwegian salmon production and use of 
antibiotics during the period 1980–2007. An early response, as in many other animal 
production operations, was to mix antibiotics into the feed. During most of the 1980s, the 
use of antibiotics increased even more rapidly than the production of salmon, with 48,570 
kilos being used in the highest year (1987) for a production of 46,000 tonnes. The use of 
antibiotics had significant negative environmental externalities, particularly on the ben-
thic fauna around the farms. 
 Pollution, including the use of antibiotics that negatively impacted the local environ-
ment, also influenced the productivity of salmon farms at each location, giving farmers 
incentives to reduce the local pollution (Asche, guttormsen, and Tveteras 1999). Together 
with regulatory measures to combat disease, the negative feedback effects on productivity 
1 There lacks transparency in reporting disease in most places, particularly in the UK, so although it is clear that 
no major outbreaks have taken place, one cannot say much about the frequency and distribution of outbreaks.
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also provided the industry with incentives to reduce the use of antibiotics. A major break-
through came with the first vaccine, which was commercially introduced in 1991.2 As one 
can see in figure 1, this rapidly reduced the use of antibiotics, and in 2007 649 kilo was 
used for the production of 822,000 tonnes. The increased use of antibiotics in the 1980s 
illustrates that it takes time to detect and address a problem. However, the solution (the 
vaccine in this case) can reduce the environmental impact of the industry significantly, as 
suggested by Tveterås (2002).
2 Currently, most Norwegian smolts are vaccinated. It is worthwhile to note that the vaccines are not effective 
against all diseases and that there is an important relationship between breeding goals with respect to disease 
resistance and vaccines.
3 There is also significant production of salmon trout and coho in Chile. in 2008 the production of salmon trout 
was 179,000 tonnes and coho was 116,000 tonnes. however, there is no indication that the reduction in Atlantic 
salmon production led to an increase in the production of these species.
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Figure 1. norwegian Salmon Production and Antibiotics Use, 1980-2007
Source: FAO 2009; kontali 2009; Tveterås, S. 2002; norwegian institute of Public health 2009.
 While the industry has certainly learned a lot about combating salmon diseases in the 
Northern Hemisphere, they remain part of the productive environment and are still able to 
bankrupt individual companies in Norway and Scotland—the two countries where salmon 
aquaculture first reached significant quantities. however, their effects are limited for the 
industry at large. In Eastern Canada and the Faroe Islands, on the other hand, ISA caused 
significant damage after the turn of the century. The Faroe islands were particularly hard 
hit, as production was reduced to just one fifth of what it was at its peak, despite sev-
eral companies from other countries with ISA experience operating there. Hence, disease 
seems to spread faster than experience on how to combat it.
Chilean Production and ISA
Chile is the last of the major salmon-producing nations where aquaculture commenced. 
Production of Atlantic salmon is shown in figure 2 from 1991, the first year when produc-
tion exceeded 10,000 tonnes.3 Until 2005, Chile was the fastest-growing salmon producer 
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Figure 2. Chilean Production of Atlantic Salmon, 1991-2011
Sources: FAO 2009; kontali 2009; 2009-2011 (authors’ forecast).
in the world, overtaking Scotland as the second largest producer of salmon (including 
coho and salmon trout) in 1992 and Atlantic salmon in 2000. in 2005, total Chilean 
production was only a few thousand tonnes shy of Norwegian production and of Chile 
becoming the world’s largest salmon producer.
 growth in Atlantic salmon production in Chile started to stagnate in 2005, and pro-
duction peaked in 2005. This is an indication that there were problems earlier, despite the 
fact that the first report of the iSA outbreak was in 2007. A source indicates that strains 
of iSA have been present in Chile since the late 1990s (kibenge et al. 2009). however, it 
is still very hard to obtain any information with respect to the prevalence of viruses and 
disease in Chile. When Marine Harvest reported the outbreak of ISA in 2007, it was, at 
least in public, regarded by the industry as a separate problem for the company (Carvajal 
2009). Although there were more reports of disease outbreaks in 2008, they were still 
regarded as single occurrences, and there was little sense that this was a problem for the 
industry at large. Only in late 2008 did a majority of the companies start to regard iSA as 
a challenge that required consorted action by the industry. The government got seriously 
involved, but the industry discovered that the government had no tools to coordinate the 
effort (The Economist 2009).
 As the disease is now playing out, it seems to be at least as serious as what happened 
on the Faroe Island in relative terms, and much larger in absolute terms, as the Chilean 
industry is much bigger. A number of companies have now emptied their pens, and it is in 
the production numbers for 2009 that one will start to see how hard the industry is being 
hit. The production volume is highly uncertain, but most commentators indicate numbers 
around 200,000 tonnes (Carvajal 2009; kontali 2009; Diario Financiero 2009). it is also 
reported that the smolt release in 2009 is down to less than a tenth of what it was in 2007. 
This indicates that there will be very little fish to harvest in 2010 and eventually in 2011, 
and even with good growth rates, Chilean output is unlikely to reach much above 100,000 
tonnes. This means that compared to the production level in 2007, production will be re-
duced cumulatively by at least 700,000 tonnes during the period 2009–11, and production 
value will be reduced by more than 2 billion USD.
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Why Wasn’t the Industry Prepared? 
What any observer of this crisis will wonder is why wasn’t the Chilean industry prepared 
at all? After all, the companies operating in Chile knew that the ISA virus was present 
and that it had caused serious problems in all other major salmon-producing countries. 
The lack of an adequate response is even more surprising, given that several of the 
multinational companies have considerable experience with the disease from other pro-
duction areas. In addition, why was there such a lack of transparency about the problems? 
We know that Marine harvest was the first company that reported the disease in 2007 
and that there has been significant reluctance among other companies to report disease 
outbreaks. hence, the disease was allowed to spread for at least one year after the first 
outbreak was reported without the introduction of countermeasures (Carvajal 2009). The 
production numbers for Atlantic salmon in figure 2 give the impression that the disease 
problems were prevalent earlier than they were reported, as it is hard to come up with 
other explanations why production peaked in 2005.
 One likely reason why disease was not combated earlier is the economics of the op-
eration. Salmon is an exotic species in Chile, as are the diseases. Hence, when salmon 
farming commenced in Chile in the late 1980s, the local fauna was disease free. Moreover, 
with liberal regulations the producers could focus on scale economies that are significant in 
the industry (guttormsen 2002; Asche, Roll, and Tveteras 2009) and possibly also external 
economies of scale that have been documented in Norway (Tveteras 2002). 
 The Chilean industry seems, on the other hand, to have overlooked the significant 
production risk that has been documented for the industry (Asche and Tveteras 1999; 
kumbhakar and Tveteras 2003). Disregarding the production risk posed by disease out-
breaks may initially have been good for the competitiveness of the Chilean industry, as 
most risk-reducing measures are costly. In particular, the use of freshwater lakes rather 
than land-based closed smolt plants reduced investments in smolt production. Unvacci-
nated fish grow faster than vaccinated fish, implying lower production costs. imports of 
fish roe continued in significant quantities, allowing the industry to proceed without en-
acting its own breeding programs.4 Maybe this is sensible as long as disease is not present 
in the local fauna. However, when the Chilean industry knows the effects of disease in 
other countries and still does not take any measures, it seems irresponsible.
 A problem is, of course, the lack of transparency and underreporting of disease. As 
noted above, there are strong indications that it was known that the ISA virus was pres-
ent in Chile in the late 1990s. Moreover, the peak in 2005 of Atlantic salmon production 
suggests that the disease problems started earlier than the first iSA report made by Ma-
rine Harvest in 2007. Another indicator of disease outbreaks prior to 2007 is the use of 
antibiotics, which the Chilean government reported in July 2009 was 326 metric tonnes 
in 2008, down from 386 tonnes in 2007 (Ministerio de economía, Fomento y Recon-
strucción 2009). Chile used 350 times more antibiotics than norway per kilo of salmon 
produced in 2008. In 2003 the Chilean industry used 134 tonnes, 318 times more than in 
Norway per kilo produced.5 As these three years are the only ones we have information 
on with respect to antibiotic use in Chile, it is hard to discuss trends. However, it seems 
clear that the Chilean industry has followed the development that figure 1 shows for the 
norwegian industry in the 1980s, but so far clearly without passing the peak. Moreover, 
it is hard to come up with other explanations than that they were combating disease given 
4 This is important, since it seems that imported roe is a carrier of the iSA virus to Chile (Carvajal 2009). Of 
course, since salmon is an exotic species, the first roe had to be imported, but it is an interesting argument 
whether those imports should have been abandoned at some point and overtaken by domestic producers as a 
risk-reducing measure.
5 <http://www.patagoniatimes.cl/index.php/20080708584/news/Salmon-news/nYT-SOURCe-biTeS-bACk-
SLAMS-ChiLeS-SALMOn-inDUSTRY.html>.
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the large quantities of antibiotics used. The recently reported figures contrast the norwe-
gian figures shown in figure 1, indicating very different strategies in combating disease.
 One may wonder why companies that have experience with iSA and other diseases 
from other countries have chosen not to use this experience in Chile, and why Chilean 
authorities have failed to learn anything from the disease outbreaks in the other countries 
and only recently introduced new measures, such as increased inspections of farming fa-
cilities, new zoning regulations, etc. however, the iSA outbreaks in Canada and the Faroe 
Islands certainly indicate that the Chilean case is not unique. The fact that ISA has been 
and still is a serious disease in Norway and Scotland, but does not threaten more than at 
most a few companies in a limited region, shows that experience from combating other 
diseases also helps limit new disease.
Concluding Remarks
Disease is a part of animal production, and as such it is not surprising that it is also a part 
of aquaculture. As intensive aquaculture is a relatively new industry, one can learn about 
disease only as it occurs. When that happens, it takes time to learn how to most effective-
ly combat each disease. The experience in Norway and Scotland indicates that developing 
disease management schemes is possible and that experience from combating some dis-
eases also helps in preventing or reducing the impact of new diseases. As in agriculture, 
government has an important role to play in providing regulations and in implementing 
emergency measures that help to coordinate the industry in its preventive efforts.
 In this light, the consequences of the ISA outbreaks in Canada, the Faroe Islands, and 
now in Chile, are discouraging. Even in an industry like salmon farming where produc-
tion is limited to a few countries and with several multinational companies that have the 
ability to transfer knowledge between these countries, there actually seems to be very 
little transfer of experiences in disease management. hence, iSA wreaked havoc first in 
the bay of Fundy, then the Faroe islands, and finally in Chile, despite the experiences of 
Norway and Scotland. Moreover, regardless of the importance of different government 
bodies, the governments in these different countries seem to have a very limited capacity 
to learn from other countries that have faced similar challenges.
 When it is so difficult to learn from others’ experiences in salmon aquaculture, a 
relatively transparent industry present only in relatively developed countries, disease will 
create an even larger challenge to aquaculture development in less developed countries. 
To some extent, the experience from shrimp and other species has already demonstrated 
these governance problems (bondad-Reantaso et al. 2005). However, even if disease is 
present, the experience from Norway and Scotland indicates that large-scale aquaculture 
can be conducted in a sustainable manner (Asche 2008). The current disease problems in 
Chile demonstrate that good governance is essential to reach this objective.
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